Skip to main content

Opioid agonist treatment prescribing standards for NPs coming into effect

The effective date is Feb. 14, 2018

posted Feb. 7, 2018

CRNBC is pleased to announce the nurse practitioner (NP) standards, limits and conditions approved by the CRNBC Board on June 26, 2017, for prescribing of opioid agonist treatment (OAT) for opioid use disorder will come into effect Feb. 14, 2018. These standards will be incorporated into the Scope of Practice for Nurse Practitioners, beginning on p. 30. Note that the previous standards, limits and conditions for continuation prescribing of buprenorphine-naloxone will be rescinded on Feb. 14, 2018.

Collaboration with our partners

CRNBC would like to thank our partners, including the BC Centre on Substance Use, College of Physicians and Surgeons of BC, the College of Pharmacists of BC, the BC Ministry of Health and others for their support in reaching this important milestone. We also thank the many nurse practitioners who contributed their time and expertise during our consultations.

These partners have helped ensure NPs in B.C. are held to the same high standards as other prescribers and will be supported to practise safely and competently. The college is proud to be part of a responsive and collaborative community of experts working together to address challenges such as the opioid overdose crisis within our province.

Requirements for prescribing

Nurse practitioners who wish to prescribe opioid agonist treatment must meet the requirements set out in the CRNBC Scope of Practice for Nurse Practitioners. Information about OAT education, preceptorships, and clinical care guidance is available from the BC Centre on Substance Use.

Please note that prescribing methadone for analgesia remains out of scope. Please contact us if you have questions.

Please visit the OAT section of our site for all the information.

Home > About CRNBC > Announcements > 2018 Announcements > Opioid agonist treatment prescribing standards for NPs coming into effect